Dermapharm Holding financials at a glance

The revenue of Dermapharm Holding is reported as 1.13535 billion Euro in the fiscal year 2023. The earnings were 1.48 Euro per share in 2023, which was 47.52 lower than 2022. And about 0.17788 billion Euro are reported as free cash flow in the financials of Dermapharm Holding 2023. Dividends of 0.88 Euro per share were paid to shareholders of Dermapharm Holding stock XTRA:DMP in fiscal 2023.

1.14€B

Revenue

1.48€

Earnings Per Share

61.19%

Gross Margin %

109.50€M

Free Cash Flow

Revenue

1,135.35

Earnings Per Share

1.48

Gross Margin %

61.19

Free Cash Flow

109.50

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017
Rev.	Revenue	N/A	1.14€B	1.02€B	942.91€M	793.83€M	700.88€M	572.42€M	467.00€M
GM %	Gross Margin %	62.33%	61.19%	62.34%	63.56%	56.15%	52.83%	50.48%	45.70%
OM	Operating Margin	21.62%	16.79%	27.27%	30.82%	17.87%	16.86%	19.29%	18.70%
EPS	Earnings Per Share	1.76€	1.48€	2.82€	3.94€	1.80€	1.49€	1.46€	0.46€
Div.	Dividends	N/A	0.88€	1.05€	2.17€	0.88€	0.80€	0.77€	0.00€
PR %	Payout Ratio %	0	59.46%	37.23%	55.08%	48.89%	53.69%	52.74%	0.00%
Sha.	Shares	N/AM	53.84M	53.84M	53.84M	53.84M	53.84M	53.84M	50M
OCF	Operating Cash Flow	N/A	219.42€M	288.53€M	250.37€M	131.10€M	100.61€M	159.13€M	86.74€M
FCF	Free Cash Flow	N/A	109.50€M	249.52€M	189.17€M	90.30€M	-,281.54€M	133.16€M	12.02€M
FCFS	Free Cash Flow Per Share	4.45€	3.30€	4.63€	3.51€	1.68€	1.01€	2.49€	0.24€

Dermapharm Holding financials at a glance

Financials

Discover